Atıf İçin Kopyala
Coban N., Onat A., Guclu-Geyik F., Komurcu-Bayrak E., Can G., Erginel-Unaltuna N.
CLINICA CHIMICA ACTA, cilt.431, ss.244-249, 2014 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
431
-
Basım Tarihi:
2014
-
Doi Numarası:
10.1016/j.cca.2014.01.017
-
Dergi Adı:
CLINICA CHIMICA ACTA
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.244-249
-
Anahtar Kelimeler:
Apolipoprotein A1, Polymorphism, HDL-C, Atherogenic dyslipidemia, Blood pressure, APOLIPOPROTEIN-A-I, HIGH-DENSITY-LIPOPROTEIN, AIV GENE-CLUSTER, PLASMA APO-AI, PROMOTER REGION, HDL-CHOLESTEROL, RISK, DEFINITION, DISEASE, LOCI
-
İstanbul Üniversitesi Adresli:
Evet
Özet
Background: Variations in the apolipoprotein A-1 (APOA1) gene, a determinant of plasma high-density lipoprotein cholesterol (HDL-C) and apoA-I levels, may contribute to cardiovascular diseases. We evaluated the effects of a promoter polymorphism (-75G>A) in the APOA1 gene on metabolic syndrome (MetS) components in a Turkish population sample.